Tuberous sclerosis complex (TSC) is a neurogenetic disorder that often causes brain abnormalities leading to epilepsy, developmental delay, and autism. TSC is caused by inactivating mutations in either of the genes encoding the proteins hamartin (TSC1) and tuberin (TSC2). These proteins form a heterodimer that inhibits the mammalian target of rapamycin complex 1 (mTORC1) pathway, controlling translation and cell growth. Loss of either protein results in dysregulated mTORC1 activation, an important aspect of TSC pathogenesis. About thirty percent of TSC patients have cerebellar pathology that is poorly understood. To investigate the effects of TSC on the cerebellum, we created a mouse model in which the Tsc2 gene was selectively deleted from Purkinje cells starting at postnatal day 6 (P6). The loss of Tsc2 caused a progressive increase in Purkinje cell size and subsequent death from apoptosis. Purkinje cell loss was predominantly cell type specific and associated with motor deficits. Immunohistochemical analysis showed that both endoplasmic reticulum (ER) and oxidative stress were increased in Tsc2-null Purkinje cells. The cell death and ER stress phenotypes were rescued by treatment with the mTORC1 inhibitor rapamycin. To assess whether the murine Purkinje cell loss has a correlate to the human TSC, we analyzed postmortem cerebellum samples from TSC patients and detected Purkinje cell loss in half of the samples. Our results establish a critical role for the TSC complex in Purkinje cell survival by regulating ER and oxidative stress and reveal a novel aspect of TSC neuropathology.
Introduction
Tuberous sclerosis complex (TSC) is an autosomal dominant, tumor predisposition disorder that causes significant morbidity and mortality in children and adults (Crino et al., 2006; Marcotte and Crino, 2006) . TSC derives its name from the characteristic cerebral cortical lesions called tubers. Other brain lesions include subependymal nodules, cerebellar tubers, white matter abnormalities, and hemimegalencephaly (DiMario, 2004) . The central nervous system lesions cause morbidity and mortality due to seizures, developmental delay, autism spectrum disorders (ASD), and psychiatric disease. Although 30% of patients have cerebellar abnormalities, the neuropathology of these lesions remains largely unknown (DiMario, 2004) .
TSC is caused by germ line mutations in either one of the two genes, TSC1 or TSC2 (Consortium, 1993; van Slegtenhorst et al., 1997) . Somatic cell loss of the second allele has been demonstrated in many disease lesions, although other mechanisms of pathogenesis are likely important (Henske et al., 1997) . TSC1 encodes hamartin, a protein that biochemically interacts with the product of the TSC2 gene, tuberin, forming the functional TSC heterodimer complex (Plank et al., 1998; van Slegtenhorst et al., 1998) . A major function of the TSC complex is to regulate the rapamycin-sensitive form of the mTOR kinase, mTORC1 (Bhaskar and Hay, 2007; Huang et al., 2008; Sarbassov et al., 2005) . Activated mTORC1 phosphorylates components of the translational apparatus, thereby stimulating cap-dependent protein synthesis, cell growth, and proliferation. The TSC complex inhibits the mTORC1 kinase via the carboxy-terminal GTPase activating domain of tuberin on the small Ras-like protein Rheb (Inoki et al., 2003; Zhang et al., 2003) . Loss of either member of the TSC complex causes constitutive activation of the mTORC1 kinase, leading to unregulated phosphorylation of S6 kinase, ribosomal protein S6, and 4EBP1. The dysregulation of mTORC1 is a major determinant of the pathogenesis of TSC, as this pathway is activated in many TSC lesions (Crino et al., 2006; El-Hashemite et al., 2003) . The bacterial metabolite rapamycin, an mTORC1 inhibitor, has alleviated morbidity and mortality in several mouse models of TSC (Lee et al., 2005; Meikle et al., 2008; Zeng et al., 2008) . Rapamycin clinical trials for the treatment of human TSC have been encouraging (Bissler et al., 2008; Franz et al., 2006) .
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